{"transactions":[{"id":2948245,"issuer":{"id":122080,"kind":"organization","name":"Frazier Lifesciences Acquisition Corp","symbol":"FLAC"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}},{"id":144564,"kind":"person","name":"Frazier Lifesciences Sponsor LLC","position":2,"cik":"0001828906","reported_name":"Frazier Lifesciences Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74839,"kind":"organization","name":"Frazier Life Sciences X, L.P.","position":3,"cik":"0001790879","reported_name":"Frazier Life Sciences X, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":74837,"kind":"organization","name":"FHMLS X, L.P.","position":4,"cik":"0001790880","reported_name":"FHMLS X, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":74838,"kind":"organization","name":"FHMLS X, L.L.C.","position":5,"cik":"0001790811","reported_name":"FHMLS X, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":6,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2020-12-11T21:05:35.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":333333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Frazier Life Sciences X, L.P. is the record holder of the securities. The reported Class A ordinary shares and warrants are within the 1,000,000 units of the Issuer, as described in the Registration Statement, purchased by Frazier Lifesciences X, L.P. in the Issuer's initial public offering for $10.00 per unit. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The warrants will expire five years after the completion of the Issuer's initial business combination."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Frazier Life Sciences X, L.P. is the record holder of the securities. The reported Class A ordinary shares and warrants are within the 1,000,000 units of the Issuer, as described in the Registration Statement, purchased by Frazier Lifesciences X, L.P. in the Issuer's initial public offering for $10.00 per unit. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. Patrick J. Heron and James N. Topper are the members of FHMLS X, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. Mr. Topper is the Chief Executive Officer and Chairman of the Board of the Issuer. By virtue of Mr. Topper's representation on the Issuer's Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, FHMLS X, L.P., FHMLS X, L.L.C., Mr. Topper and Mr. Heron may be deemed directors by deputization of the Issuer. As such, each such person may be deemed to have or share beneficial ownership of the common stock held directly by Frazier Life Sciences X, L.P. Each such entity or person disclaims any such beneficial ownership of such securities except to the extent of their pecuniary interest therein."}],"balance_after":333333,"derivative":{"exercise_price":11.5,"underlying":"Class A Ordinary Shares","underlying_shares":333333},"source":{"system":"sec-edgar","filing":"0001104659-20-134761","document":"tm2037955-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000110465920134761/tm2037955-9_4seq1.xml","form_type":"4"}},{"id":2948244,"issuer":{"id":122080,"kind":"organization","name":"Frazier Lifesciences Acquisition Corp","symbol":"FLAC"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}},{"id":144564,"kind":"person","name":"Frazier Lifesciences Sponsor LLC","position":2,"cik":"0001828906","reported_name":"Frazier Lifesciences Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74839,"kind":"organization","name":"Frazier Life Sciences X, L.P.","position":3,"cik":"0001790879","reported_name":"Frazier Life Sciences X, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":74837,"kind":"organization","name":"FHMLS X, L.P.","position":4,"cik":"0001790880","reported_name":"FHMLS X, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":74838,"kind":"organization","name":"FHMLS X, L.L.C.","position":5,"cik":"0001790811","reported_name":"FHMLS X, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":6,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2020-12-11T21:05:35.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":167000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Frazier Lifesciences Sponsor LLC (the \"Sponsor\") is the record holder of the securities. The reported Class A ordinary shares and warrants are within the [465,000] private placement units of the Issuer, as described in the Issuer's Registration Statement on Form S-1 (File No. 333-250858) (the \"Registration Statement\") under the heading \"Description of Securities,\" purchased by the Sponsor for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The warrants will expire five years after the completion of the Issuer's initial business combination."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frazier Lifesciences Sponsor LLC (the \"Sponsor\") is the record holder of the securities. The reported Class A ordinary shares and warrants are within the [465,000] private placement units of the Issuer, as described in the Issuer's Registration Statement on Form S-1 (File No. 333-250858) (the \"Registration Statement\") under the heading \"Description of Securities,\" purchased by the Sponsor for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frazier Life Sciences X, L.P. is the sole member of Frazier Lifesciences Sponsor LLC. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. Patrick J. Heron and James N. Topper are the members of FHMLS X, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. Mr. Topper is the Chief Executive Officer and Chairman of the Board of Directors (the \"Board\") of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"By virtue of Mr. Topper's representation on the Issuer's Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each of Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Mr. Topper and Mr. Heron may be deemed directors by deputization of the Issuer. As such, each of such entity or person may be deemed to have or share beneficial ownership of the common stock held directly by Frazier Lifesciences Sponsor LLC. Each such entity or person disclaims any such beneficial ownership of such securities except to the extent of their pecuniary interest therein."}],"balance_after":167000,"derivative":{"exercise_price":11.5,"underlying":"Class A Ordinary Shares","underlying_shares":167000},"source":{"system":"sec-edgar","filing":"0001104659-20-134761","document":"tm2037955-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000110465920134761/tm2037955-9_4seq1.xml","form_type":"4"}},{"id":2948243,"issuer":{"id":122080,"kind":"organization","name":"Frazier Lifesciences Acquisition Corp","symbol":"FLAC"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}},{"id":144564,"kind":"person","name":"Frazier Lifesciences Sponsor LLC","position":2,"cik":"0001828906","reported_name":"Frazier Lifesciences Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74839,"kind":"organization","name":"Frazier Life Sciences X, L.P.","position":3,"cik":"0001790879","reported_name":"Frazier Life Sciences X, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":74837,"kind":"organization","name":"FHMLS X, L.P.","position":4,"cik":"0001790880","reported_name":"FHMLS X, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":74838,"kind":"organization","name":"FHMLS X, L.L.C.","position":5,"cik":"0001790811","reported_name":"FHMLS X, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":6,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2020-12-11T21:05:35.000Z","date":"2020-12-11","kind":"purchase","acquired":true,"shares":1000000,"price":10,"value":10000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Frazier Life Sciences X, L.P. is the record holder of the securities. The reported Class A ordinary shares and warrants are within the 1,000,000 units of the Issuer, as described in the Registration Statement, purchased by Frazier Lifesciences X, L.P. in the Issuer's initial public offering for $10.00 per unit. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. Patrick J. Heron and James N. Topper are the members of FHMLS X, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. Mr. Topper is the Chief Executive Officer and Chairman of the Board of the Issuer. By virtue of Mr. Topper's representation on the Issuer's Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, FHMLS X, L.P., FHMLS X, L.L.C., Mr. Topper and Mr. Heron may be deemed directors by deputization of the Issuer. As such, each such person may be deemed to have or share beneficial ownership of the common stock held directly by Frazier Life Sciences X, L.P. Each such entity or person disclaims any such beneficial ownership of such securities except to the extent of their pecuniary interest therein."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001104659-20-134761","document":"tm2037955-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000110465920134761/tm2037955-9_4seq1.xml","form_type":"4"}},{"id":2948242,"issuer":{"id":122080,"kind":"organization","name":"Frazier Lifesciences Acquisition Corp","symbol":"FLAC"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}},{"id":144564,"kind":"person","name":"Frazier Lifesciences Sponsor LLC","position":2,"cik":"0001828906","reported_name":"Frazier Lifesciences Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74839,"kind":"organization","name":"Frazier Life Sciences X, L.P.","position":3,"cik":"0001790879","reported_name":"Frazier Life Sciences X, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":74837,"kind":"organization","name":"FHMLS X, L.P.","position":4,"cik":"0001790880","reported_name":"FHMLS X, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":74838,"kind":"organization","name":"FHMLS X, L.L.C.","position":5,"cik":"0001790811","reported_name":"FHMLS X, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":6,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2020-12-11T21:05:35.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":501000,"price":10,"value":5010000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Frazier Lifesciences Sponsor LLC (the \"Sponsor\") is the record holder of the securities. The reported Class A ordinary shares and warrants are within the [465,000] private placement units of the Issuer, as described in the Issuer's Registration Statement on Form S-1 (File No. 333-250858) (the \"Registration Statement\") under the heading \"Description of Securities,\" purchased by the Sponsor for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frazier Life Sciences X, L.P. is the sole member of Frazier Lifesciences Sponsor LLC. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. Patrick J. Heron and James N. Topper are the members of FHMLS X, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. Mr. Topper is the Chief Executive Officer and Chairman of the Board of Directors (the \"Board\") of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"By virtue of Mr. Topper's representation on the Issuer's Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each of Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Mr. Topper and Mr. Heron may be deemed directors by deputization of the Issuer. As such, each of such entity or person may be deemed to have or share beneficial ownership of the common stock held directly by Frazier Lifesciences Sponsor LLC. Each such entity or person disclaims any such beneficial ownership of such securities except to the extent of their pecuniary interest therein."}],"balance_after":501000,"source":{"system":"sec-edgar","filing":"0001104659-20-134761","document":"tm2037955-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000110465920134761/tm2037955-9_4seq1.xml","form_type":"4"}}]}